{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China",
    "State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China",
    "Department of Urology, Tianjin First Central Hospital, Tianjin, China"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 17,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Yan Jin"
    },
    {
      "affs": [
        0
      ],
      "name": "Benfu Zhong"
    },
    {
      "affs": [
        0
      ],
      "name": "Jiarun Fu"
    },
    {
      "affs": [
        2
      ],
      "name": "Jiayi Liu"
    },
    {
      "affs": [
        0
      ],
      "name": "Jie Li"
    },
    {
      "affs": [
        0
      ],
      "name": "Zhanglin Li"
    },
    {
      "affs": [
        0
      ],
      "name": "Baocheng Gong"
    },
    {
      "affs": [
        0
      ],
      "name": "Chaoyu Wang"
    },
    {
      "affs": [
        0
      ],
      "name": "Shuai Man"
    },
    {
      "affs": [
        0
      ],
      "name": "Zhongyuan Li"
    },
    {
      "affs": [
        0
      ],
      "name": "Yun Liu"
    },
    {
      "affs": [
        0
      ],
      "name": "Daowei Wang"
    },
    {
      "affs": [
        0
      ],
      "name": "Jiaxing Yu"
    },
    {
      "affs": [
        0
      ],
      "name": "Wenfeng Cao"
    },
    {
      "affs": [
        0
      ],
      "name": "Qiang Zhao",
      "orcid": "0000-0003-4847-7054"
    },
    {
      "affs": [
        1
      ],
      "name": "Xiaofan Zhu"
    },
    {
      "affs": [
        0
      ],
      "name": "Yanna Cao"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/f2d01s979tj8s.bib",
  "cited_by": 0,
  "doi": "10.1136/bmjopen-2026-123958",
  "fulltext_url": null,
  "id": "f2d01s979tj8s",
  "issns": [
    "2044-6055",
    "2044-6055"
  ],
  "landing_url": "https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-123958",
  "language": null,
  "licence": "unknown",
  "licence_label": "Licence not stated",
  "licence_source": "unknown",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-02",
  "publisher": "BMJ",
  "ris": "https://research.draconitic.com/paper/f2d01s979tj8s.ris",
  "sources": [
    {
      "first_seen": "2026-11-03T00:25:11Z",
      "native_id": "10.1136/bmjopen-2026-123958",
      "source": "crossref",
      "url": "https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-123958"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "journal-openalex:F27",
      "subfield": "general"
    }
  ],
  "title": "Chidamide combined with dinutuximab beta, irinotecan and temozolomide for relapsed or refractory neuroblastoma in children: protocol for a prospective, single-centre, open-label, single-arm, phase II study in China",
  "title_text": "Chidamide combined with dinutuximab beta, irinotecan and temozolomide for relapsed or refractory neuroblastoma in children: protocol for a prospective, single-centre, open-label, single-arm, phase II study in China",
  "type": "peer-reviewed",
  "updated_at": "2026-11-04T00:26:09Z",
  "url": "https://research.draconitic.com/paper/f2d01s979tj8s",
  "venue": "BMJ Open",
  "versions": []
}